BR112022004527A2 - Composições com base em cepas bacterianas e seu uso como anti-inflamatórios - Google Patents
Composições com base em cepas bacterianas e seu uso como anti-inflamatóriosInfo
- Publication number
- BR112022004527A2 BR112022004527A2 BR112022004527A BR112022004527A BR112022004527A2 BR 112022004527 A2 BR112022004527 A2 BR 112022004527A2 BR 112022004527 A BR112022004527 A BR 112022004527A BR 112022004527 A BR112022004527 A BR 112022004527A BR 112022004527 A2 BR112022004527 A2 BR 112022004527A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial strains
- inflammatories
- compositions
- compositions based
- alternatively
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
composições com base em cepas bacterianas e seu uso como anti-inflamatórios.a presente invenção refere-se a composições b que compreendem uma mistura que compreende ou, alternativamente, que consiste em: pelo menos uma cepa bacteriana selecionada a partir de um grupo que compreende ou, alternativamente, que consiste em cepas bacterianas pertencentes às espécies lactobacillus paracasei, lactobacillus rhamnosus, bifidobacterium bifidum e bifidobacterium animalis subsp. lactis e, de preferência, pelo menos um extrato de pelo menos uma espécie de bagas que compreende uma fração polifenólica das ditas bagas. além disso, a presente invenção refere-se às ditas composições b para uso como agentes imunomoduladores e anti-inflamatórios.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000016865A IT201900016865A1 (it) | 2019-09-20 | 2019-09-20 | Composizioni a base di ceppi batterici e loro uso come antinfiammatori |
| PCT/IB2020/058778 WO2021053642A1 (en) | 2019-09-20 | 2020-09-21 | Compositions based on bacterial strains and their use as anti-inflammatories |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022004527A2 true BR112022004527A2 (pt) | 2022-06-07 |
Family
ID=69469004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022004527A BR112022004527A2 (pt) | 2019-09-20 | 2020-09-21 | Composições com base em cepas bacterianas e seu uso como anti-inflamatórios |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220354910A1 (pt) |
| EP (1) | EP4031158A1 (pt) |
| JP (1) | JP2023507704A (pt) |
| CN (1) | CN114728029A (pt) |
| AU (1) | AU2020350216A1 (pt) |
| BR (1) | BR112022004527A2 (pt) |
| CA (1) | CA3154981A1 (pt) |
| IL (1) | IL291463A (pt) |
| IT (1) | IT201900016865A1 (pt) |
| MX (1) | MX2022003373A (pt) |
| WO (1) | WO2021053642A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| IT202100008300A1 (it) * | 2021-04-01 | 2022-10-01 | Bll Invest S R L | Ceppi di batteri inattivati, quali batteri vitali ma non coltivabili, loro composizioni e loro uso |
| IT202100017855A1 (it) * | 2021-07-06 | 2023-01-06 | Lac2Biome S R L | Bacteria strains for topical skin care |
| IT202100018740A1 (it) * | 2021-07-15 | 2023-01-15 | Sofar Spa | Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati |
| CN116396884A (zh) * | 2022-08-15 | 2023-07-07 | 江苏华熙益能生物科技有限公司 | 鼠李糖乳杆菌和一种抑制幽门螺杆菌的组合物 |
| CN116333945B (zh) * | 2023-05-12 | 2023-08-01 | 成都海若健康科技有限公司 | 一种抗幽门螺杆菌的鼠李糖乳酪杆菌puk09及其应用、产品及方法 |
| CN116904346A (zh) * | 2023-06-06 | 2023-10-20 | 石河子大学 | 动物双歧杆菌乳亚种hn-3在沙枣果汁发酵中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090214594A1 (en) * | 2006-06-13 | 2009-08-27 | Nestec S.A. | Prevention and Treatment of Otitis Media with Non-Pathogenic Bacterial Strains |
| DK2403510T3 (da) * | 2009-03-05 | 2020-03-23 | Probiotical Spa | Bakteriestammer med en høj antiinflammatorisk aktivitet |
| ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
| WO2015172191A1 (en) * | 2014-05-12 | 2015-11-19 | Medlab Ip Pty Ltd | Probiotic compositions and uses thereof for treatment of obesity-related disorders |
| EP2990045B1 (en) * | 2014-08-26 | 2016-11-16 | Chr. Hansen A/S | Bifidobacterium animalis subsp. lactis for use in decreasing abdominal pain in a postmenopausal woman |
| MA45327A (fr) * | 2016-05-13 | 2019-03-20 | Sofar Spa | Utilisation de probiotiques pour améliorer l'absorption des protéines |
| US11207358B2 (en) * | 2016-12-16 | 2021-12-28 | Compagnie Gervais Danone | Probiotic composition comprising Lactobacillus rhamnosus and Lactobacillus paracasei and methods thereof |
| IT201700101704A1 (it) * | 2017-09-12 | 2019-03-12 | Sofar Spa | Nuovo uso per trattamento delle infezioni da clostridium difficile |
| US11534468B2 (en) * | 2017-12-06 | 2022-12-27 | Lac2biome S.r.l. | Composition based on probiotics and uses thereof |
| IT201900011193A1 (it) * | 2019-07-08 | 2021-01-08 | Sofar Spa | Ceppo di batteri Bifidobacterium bifidum, sue composizioni e relativi usi |
| IT201900016850A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e estratti di bacche e loro uso come antinfiammatori |
-
2019
- 2019-09-20 IT IT102019000016865A patent/IT201900016865A1/it unknown
-
2020
- 2020-09-21 BR BR112022004527A patent/BR112022004527A2/pt unknown
- 2020-09-21 CN CN202080065600.XA patent/CN114728029A/zh active Pending
- 2020-09-21 AU AU2020350216A patent/AU2020350216A1/en active Pending
- 2020-09-21 MX MX2022003373A patent/MX2022003373A/es unknown
- 2020-09-21 US US17/762,017 patent/US20220354910A1/en active Pending
- 2020-09-21 EP EP20793140.3A patent/EP4031158A1/en active Pending
- 2020-09-21 WO PCT/IB2020/058778 patent/WO2021053642A1/en unknown
- 2020-09-21 CA CA3154981A patent/CA3154981A1/en active Pending
- 2020-09-21 JP JP2022518339A patent/JP2023507704A/ja active Pending
-
2022
- 2022-03-17 IL IL291463A patent/IL291463A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022003373A (es) | 2022-04-11 |
| JP2023507704A (ja) | 2023-02-27 |
| EP4031158A1 (en) | 2022-07-27 |
| IT201900016865A1 (it) | 2021-03-20 |
| US20220354910A1 (en) | 2022-11-10 |
| IL291463A (en) | 2022-05-01 |
| AU2020350216A1 (en) | 2022-03-31 |
| CN114728029A (zh) | 2022-07-08 |
| CA3154981A1 (en) | 2021-03-25 |
| WO2021053642A1 (en) | 2021-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022004527A2 (pt) | Composições com base em cepas bacterianas e seu uso como anti-inflamatórios | |
| BR112022004976A2 (pt) | Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios | |
| BR112022004569A2 (pt) | Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais | |
| BR112022004432A2 (pt) | Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais | |
| Mohanty et al. | In vitro evaluation of adherence and anti-infective property of probiotic Lactobacillus plantarum DM 69 against Salmonella enterica | |
| Rehaiem et al. | Assessment of potential probiotic properties and multiple bacteriocin encoding-genes of the technological performing strain Enterococcus faecium MMRA | |
| ES2524432T3 (es) | Bacterias del ácido láctico como cepas probióticas y composiciones que contienen las mismas | |
| BR112018077266A2 (pt) | composições compreendendo cepas bacterianas | |
| NZ777234A (en) | Compositions comprising bacterial strains | |
| BRPI1014081A2 (pt) | uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma | |
| SI3048165T1 (en) | NEW SEV BACTERIA BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND ITS APPLICATION FOR INJURY AND / OR PREVENTION OF OVERVIEW OF BODY WEALTH AND BALANCE AND ASSOCIATED DISEASES | |
| BR112022008533A2 (pt) | Composição para aumento da biodisponibilidade sanguínea de aminoácidos, seu uso, produto alimentício, uso de uma mistura, e usos de cepas bacterianas probióticas | |
| BR112018003123A2 (pt) | composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada | |
| BR112018075625A2 (pt) | composição nutricional compreendendo um probiótico para a prevenção e/ou tratamento de distúrbios de ansiedade e condições relacionadas em um mamífero | |
| BR112019001116A2 (pt) | composição probiótica usada no tratamento e/ou prevenção da dermatite atópica | |
| WO2009013709A3 (en) | Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same | |
| BR112012028893A2 (pt) | composições imunoestimuladoras e de vacina | |
| BR112012023028A2 (pt) | bactérias do ácido láctico para doença celíaca. | |
| MX2021009398A (es) | Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso. | |
| MX2022007999A (es) | Streptococcus thermophilus negativo a sacarosa para su uso en la preparación de productos fermentados. | |
| MX2017007654A (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas. | |
| WO2017199022A3 (en) | Lactobacillus rhamnosus lysate compositions and uses thereof | |
| UA94056C2 (uk) | Застосування специфічних молочнокислих бактерій для одержання імуномодулюючих композицій | |
| CO2017007338A2 (es) | Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina | |
| HRPK20130487B3 (hr) | Formulacija probiotika s apigeninom i ekstraktom paprene metvice |